[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2020904824A0 - Treatment for Coronavirus infection and associated cytokine toxicity (2) - Google Patents

Treatment for Coronavirus infection and associated cytokine toxicity (2)

Info

Publication number
AU2020904824A0
AU2020904824A0 AU2020904824A AU2020904824A AU2020904824A0 AU 2020904824 A0 AU2020904824 A0 AU 2020904824A0 AU 2020904824 A AU2020904824 A AU 2020904824A AU 2020904824 A AU2020904824 A AU 2020904824A AU 2020904824 A0 AU2020904824 A0 AU 2020904824A0
Authority
AU
Australia
Prior art keywords
treatment
coronavirus infection
associated cytokine
cytokine toxicity
toxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020904824A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2020904824A0 publication Critical patent/AU2020904824A0/en
Priority to JP2022554820A priority Critical patent/JP2023517239A/en
Priority to AU2021234945A priority patent/AU2021234945A1/en
Priority to CN202180031179.5A priority patent/CN115484964B/en
Priority to CA3171235A priority patent/CA3171235A1/en
Priority to EP21767048.8A priority patent/EP4117683A4/en
Priority to KR1020227035531A priority patent/KR20220159397A/en
Priority to BR112022018200A priority patent/BR112022018200A2/en
Priority to PH1/2022/552298A priority patent/PH12022552298A1/en
Priority to PCT/AU2021/050215 priority patent/WO2021179047A1/en
Priority to US17/910,220 priority patent/US20230120864A1/en
Priority to CL2022002457A priority patent/CL2022002457A1/en
Priority to US18/071,800 priority patent/US11938146B2/en
Abandoned legal-status Critical Current

Links

AU2020904824A 2020-03-12 2020-12-23 Treatment for Coronavirus infection and associated cytokine toxicity (2) Abandoned AU2020904824A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US17/910,220 US20230120864A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
EP21767048.8A EP4117683A4 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
AU2021234945A AU2021234945A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
CN202180031179.5A CN115484964B (en) 2020-03-12 2021-03-12 Treatment of coronavirus infection and related cytokine toxicity
CA3171235A CA3171235A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
JP2022554820A JP2023517239A (en) 2020-03-12 2021-03-12 Treatment of coronavirus infection and associated cytokine toxicity
KR1020227035531A KR20220159397A (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and related cytokine toxicity
BR112022018200A BR112022018200A2 (en) 2020-03-12 2021-03-12 TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE TOXICITY
PH1/2022/552298A PH12022552298A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
PCT/AU2021/050215 WO2021179047A1 (en) 2020-03-12 2021-03-12 Treatment for coronavirus infection and associated cytokine toxicity
CL2022002457A CL2022002457A1 (en) 2020-03-12 2022-09-08 Treatment of coronavirus infection and cytokine-associated toxicity
US18/071,800 US11938146B2 (en) 2020-03-12 2022-11-30 Treatment for coronavirus infection and associated cytokine toxicity

Publications (1)

Publication Number Publication Date
AU2020904824A0 true AU2020904824A0 (en) 2021-01-21

Family

ID=

Similar Documents

Publication Publication Date Title
WO2021188969A3 (en) Coronavirus vaccines and methods of use
EP3912623C0 (en) Pd-0184264 for the treatment of coronavirus infections and/or covid-19 cytokine storm
WO2005000878A3 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
UA88463C2 (en) Pharmaceutical composition comprising compound i and method of treating hiv infection
EP4117683A4 (en) Treatment for coronavirus infection and associated cytokine toxicity
EP4117630A4 (en) Treatment of coronavirus infection
EP4121022A4 (en) Compositions and methods for treating and preventing a coronavirus infection
EP4186496A4 (en) Application of cannabidiol in treatment of coronavirus infections
EP4199950A4 (en) Methods and compositions for treating coronavirus infections
WO2023122260A3 (en) Inhibitors of sars-cov-2
IL277315B (en) Methods and composition for treating coronavirus infection
EP4093758A4 (en) Methods and compositions for treating and preventing viral infection
EP4216961A4 (en) Compositions and methods for treatment of coronavirus infection
EP4178575A4 (en) Compositions and methods for inhibiting and treating coronavirus infections
WO2022053993A3 (en) Treatments for sars-cov-2 infection (covid-19)
EP4121038A4 (en) Compositions and methods for the treatment of coronavirus infection and respiratory compromise
AU2020904824A0 (en) Treatment for Coronavirus infection and associated cytokine toxicity (2)
EP4164619A4 (en) Treatment methods and formulations
EP4157327A4 (en) Compositions and methods for preventing and treating sars-cov-2 infection
EP4074310A4 (en) Drug for treating coronaviral and retroviral infections and hepatitis c
AU2020900751A0 (en) Treatment for coronavirus infection and associated cytokine toxicity
MX2023009041A (en) Use of proteasome inhibitors in the treatment of coronavirus infections.
WO2023003951A3 (en) Compositions and methods for the treatment of herpes simplex virus infection
EP4009981A4 (en) Method and compositions for treating coronavirus infection
EP4103192A4 (en) Compositions and methods for treating coronavirus infections